Tobacco Therapy Helps Dual Users Quit Smoking: Study

Jul.29.2022
Tobacco Therapy Helps Dual Users Quit Smoking: Study
Tobacco treatment including nicotine replacement therapy and behavioral support can help dual users of cigarettes and e-cigarettes quit smoking.

According to a study published online in Thorax, tobacco treatments such as nicotine replacement therapy and behavioral support therapy can assist dual users of traditional cigarettes and e-cigarettes in quitting smoking.


Dr. Brendan T. Hayden, from the University of Washington School of Medicine, evaluated whether formal tobacco treatment (pharmacotherapy and/or behavioral support) enhanced smoking cessation among individuals who use both cigarettes and e-cigarettes. The analysis included 111,823 outpatients who visited tertiary care medical centers between June 2018 and June 2020.


During the course of the study, researchers found that dual use of cigarettes and e-cigarettes significantly increased every six months (0.8%, 1.1%, 1.8%, and 2.3% respectively). At the 12-month mark, e-cigarette users had a higher quit rate (20.8%) compared to non-smokers (16.8%; adjusted relative risk was 1.354). Individuals receiving tobacco treatment had a higher quit rate at 12 months (29.1%) compared to non-smokers (19.6%; adjusted relative risk was 1.238).


In a statement, Hayden mentioned that although current guidelines do not recommend quitting smoking, they have indeed found that traditional tobacco treatments approved by the US Food and Drug Administration, such as nicotine replacement therapy and behavioral support therapy, can help those who use these products quit smoking.


Click to see the original research article.


Sorry, as an AI language model, I cannot provide a translation without the text to be translated. Please provide the text.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Brazilian Law Enforcement Seizes Large Haul of E-Cigarettes and Controlled Items, Total Value Around $18,000
Brazilian Law Enforcement Seizes Large Haul of E-Cigarettes and Controlled Items, Total Value Around $18,000
Brazil's Federal Revenue Service seized over $17,957 worth of illegal items, including ecstasy, e-cigarettes, and unprescribed steroids, during a large-scale inspection at Porto Alegre's airport and postal center. The operation aims to protect youth from illicit drugs and unregulated goods, with plans for continued enhanced inspections.
Aug.04 by 2FIRSTS.ai
South Korea Again Delays Review of Tobacco Act Amendment; Synthetic Nicotine Still in a Regulatory Gap
South Korea Again Delays Review of Tobacco Act Amendment; Synthetic Nicotine Still in a Regulatory Gap
On September 9, South Korea’s National Assembly again postponed reviewing amendments to the Tobacco Business Act that would classify synthetic nicotine as tobacco, prolonging a regulatory gap that leaves such products untaxed and legally sold near schools and via vending machines. This delay persists despite 36 of 38 OECD countries regulating synthetic nicotine at tobacco-equivalent standards and a November 2024 government study indicating substantial harms. The subcommittee plans to reconvene S
Sep.11 by 2FIRSTS.ai
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
The U.S. FDA will launch a pilot program to accelerate reviews of nicotine pouch products from Philip Morris International, Altria, BAT’s Reynolds American, and Turning Point Brands, aiming to complete the process by December 2025. The move, driven by pressure from the Trump administration, seeks to address past multi-year approval delays. Nicotine pouches, the fastest-growing U.S. smoking alternative, are seen as lower-risk but raise youth appeal concerns.
Sep.08
WHO Representative in Malaysia: Country Should Follow Neighbors in Implementing a Full E-cigarette Ban
WHO Representative in Malaysia: Country Should Follow Neighbors in Implementing a Full E-cigarette Ban
The World Health Organization’s representative in Malaysia has called for a nationwide ban on e-cigarettes, citing regulatory gaps that put children and adolescents at risk. While some Malaysian states have imposed bans, a unified national policy is needed to close enforcement loopholes.
Jul.28 by 2FIRSTS.ai
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Health professionals worldwide are urging a shift from abstinence-only tobacco policies toward evidence-based harm reduction. Despite bans, smoking remains prevalent in countries like India, while prohibition fuels black markets in Europe and misinformation among doctors in the U.S. Many argue that regulated alternatives could save lives where cessation fails.
Sep.09
Research Brief | Current Use of Cigarettes, E-Cigarettes, and Cannabis Is Significantly Associated with Xerostomia
Research Brief | Current Use of Cigarettes, E-Cigarettes, and Cannabis Is Significantly Associated with Xerostomia
About 9.7% of 29,721 U.S. adults (18+) surveyed in 2022–2023 reported their mouth felt dry “frequently” or “always.” After multivariable adjustment, past-30-day use of cigarettes (AOR ≈ 1.52), e-cigarettes (≈ 1.46), or cannabis (≈ 1.57) was each linked to higher odds of xerostomia. Daily use showed stronger associations (cigarettes ≈ 1.67; e-cigarettes ≈ 1.80; cannabis ≈ 2.15). Concurrent use of all three products had the highest odds (AOR ≈ 3.80). The authors suggest dental professionals factor
Sep.12 by 2FIRSTS.ai